Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 5
2016 4
2017 5
2018 1
2019 3
2020 15
2021 21
2022 16
2023 24
2024 14

Text availability

Article attribute

Article type

Publication date

Search Results

103 results

Results by year

Filters applied: . Clear all
Page 1
Characteristics and outcomes of patients with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia after failure of a frontline ponatinib-containing therapy.
Short NJ, Jabbour E, Nasr LF, Jain N, Haddad FG, Issa GC, Sasaki K, Senapati J, Kebriaei P, Garris R, Konopleva M, Ravandi F, Kantarjian H. Short NJ, et al. Among authors: issa gc. Am J Hematol. 2024 Apr 12. doi: 10.1002/ajh.27329. Online ahead of print. Am J Hematol. 2024. PMID: 38607091 No abstract available.
Are there new relevant therapeutic endpoints in the modern era of the BCR::ABL1 tyrosine kinase inhibitors in chronic myeloid leukemia?
Kantarjian H, Branford S, Breccia M, Cortes J, Haddad FG, Hochhaus A, Hughes T, Issa GC, Jabbour E, Nicolini FE, Sasaki K, Xavier-Mahon F. Kantarjian H, et al. Among authors: issa gc. Leukemia. 2024 Mar 26. doi: 10.1038/s41375-024-02229-3. Online ahead of print. Leukemia. 2024. PMID: 38531949 Review. No abstract available.
Influence of co-mutational patterns in disease phenotype and clinical outcomes of chronic myelomonocytic leukemia.
Montalban-Bravo G, Rodriguez-Sevilla JJ, Swanson DM, Kanagal-Shamanna R, Hammond D, Chien K, Sasaki K, Jabbour E, DiNardo C, Takahashi K, Short N, Issa GC, Pemmaraju N, Kadia T, Ravandi F, Daver N, Borthakur G, Loghavi S, Pierce S, Bueso-Ramos C, Kantarjian H, Garcia-Manero G. Montalban-Bravo G, et al. Among authors: issa gc. Leukemia. 2024 Feb 28. doi: 10.1038/s41375-024-02190-1. Online ahead of print. Leukemia. 2024. PMID: 38418609 No abstract available.
Targetable genetic abnormalities in patients with acute myeloblastic leukemia across age groups.
Bataller A, DiNardo CD, Bazinet A, Daver NG, Maiti A, Borthakur G, Short N, Sasaki K, Jabbour EJ, Issa GC, Pemmaraju N, Yilmaz M, Montalban-Bravo G, Loghavi S, Garcia-Manero G, Ravandi F, Kantarjian HM, Kadia TM. Bataller A, et al. Among authors: issa gc. Am J Hematol. 2024 Apr;99(4):792-796. doi: 10.1002/ajh.27236. Epub 2024 Feb 15. Am J Hematol. 2024. PMID: 38361282
103 results